# V1 Empirics Check — openai/gpt-oss-120b (Variant A)

**Model:** openai/gpt-oss-120b
**Variant:** A
**Date:** 2026-03-14T22:57:53.113124

---

**1. Idea Fidelity**  

The manuscript stays very close to the original manifest. It (i) uses the same three outcome indicators from the Fingertips API (dental decay in 5‑year‑olds, reception‑year obesity, and COPD admissions as a placebo); (ii) exploits cross‑local‑authority (LA) variation in the Index of Multiple Deprivation (IMD) as a *continuous* measure of treatment intensity; and (iii) adopts the two‑stage difference‑in‑differences (Di‑D) design that distinguishes the “announcement‑reformulation” window (2016/17) from the post‑implementation window (2018/19 onward). The paper also reproduces the decomposition (β₁ = reformulation‑only, β₂ – β₁ = additional price/tax effect) and runs an event‑study and a COPD placebo exactly as proposed.  

The only minor departure is the choice of a linear IMD index (standardised) rather than quintile‑specific interactions for the main regressions – a reasonable simplification that does not violate the original plan. Overall, the submitted paper faithfully implements the idea.  

---

**2. Summary**  

This paper evaluates whether the UK Soft Drinks Industry Levy (SDIL) reduced the deprivation gap in two childhood health outcomes—dental decay and obesity—by exploiting LA‑level variation in baseline deprivation as a continuous treatment intensity. Using a panel Di‑D framework that separates the pre‑implementation reformulation period from the post‑implementation period, the authors find no differential improvement in dental decay and, after accounting for pre‑trends, no credible evidence that obesity outcomes were affected differentially. A COPD admission placebo confirms that the design is not picking up spurious trends. The authors conclude that a reformulation‑driven levy, while successful at the population level, is essentially equity‑neutral.  

---

**3. Essential Points**  

1. **Parallel‑Trends Assumption for Obesity Is Not Satisfied**  
   The event‑study (Panel B of Table 8) shows statistically significant pre‑trend coefficients for the obesity outcome, indicating that the deprivation‑obesity gradient was already widening before the SDIL. Yet the baseline specification treats the post‑announcement coefficient as the causal effect, which is misleading. A Di‑D estimate that does not satisfy parallel trends cannot be interpreted as the effect of the SDIL.  

2. **Treatment Timing and Lag Structure for Dental Decay Are Ambiguous**  
   The paper treats the 2018/19 wave as the start of “post‑reform” exposure, but the biological lag for dental decay suggests that children surveyed in 2018/19 were born circa 2013‑14 and had the bulk of their early‑life exposure **before** the reformulation window. The “full exposure” specification (2021/22 onward) is more appropriate, yet the authors present it only as a secondary robustness check and do not discuss its implications for the null finding in depth.  

3. **Use of a Single Continuous Deprivation Index May Mask Heterogeneous Effects**  
   By interacting a standardised IMD score with the post‑period dummy, the analysis imposes a linear relationship between deprivation and the treatment effect. The original manifest emphasised “deprivation quintiles” and a decomposition of the effect across the distribution. The current specification cannot test whether the relationship is nonlinear (e.g., stronger effects at the very top of the deprivation range) and therefore may overlook important heterogeneity.  

*If these three issues are not addressed, the paper’s central claim—that the SDIL’s equity impact is null—remains unsupported.*  

---

**4. Suggestions**  

Below are detailed, concrete recommendations that will strengthen the identification strategy, improve the robustness of the results, and make the contribution clearer. They are organized by theme; you can implement them in any order that fits your timeline.

---

### A. Strengthening the Parallel‑Trends Assumption  

| Issue | Recommendation |
|-------|----------------|
| **Obesity pre‑trend** | 1. **Re‑estimate the main Di‑D using a *dynamic* specification that allows for time‑varying treatment effects** (e.g., a stacked‑DiD or event‑study with leads and lags, but *excluding* leads that are statistically different from zero).<br>2. **Include LA‑specific linear (or quadratic) trends** for the obesity regression and report how the post‑announcement coefficient changes. The current Table 9 (col 4) shows a reduced coefficient (0.255) but it remains significant; discuss whether this residual effect plausibly reflects the SDIL or an omitted trend.<br>3. **Consider an alternative control group**: e.g., restrict the sample to LAs in the bottom 20 % of baseline sugary‑drink consumption (if such data are available from market research) or to a subsample of LAs with relatively flat obesity trends pre‑2015. If the effect disappears, the original estimate was likely driven by the pre‑trend. |
| **Placebo outcomes** | 1. Add a second placebo outcome that is *positively* related to deprivation but a priori unrelated to sugary‑drink consumption (e.g., asthma hospitalisations). Showing null effects across multiple placebos will increase confidence that the design is not picking up generic deprivation‑driven health trends. |

### B. Clarifying the Lag Structure for Dental Decay  

| Issue | Recommendation |
|-------|----------------|
| **Biological lag** | 1. **Define the treatment indicator more rigorously** based on birth cohorts. For each survey wave, compute the proportion of a child’s first five years that fell after the reformulation window (e.g., a child surveyed in 2021/22 was born 2016/17 → ~80 % of exposure post‑reform). Use this proportion as a continuous “exposure” variable rather than a binary post‑2018 dummy. This will yield a more precise estimate of the reformulation‑only channel. <br>2. **Report results for three specifications**: (i) binary post‑2018; (ii) binary post‑2021 (full exposure); (iii) continuous exposure. Show whether the coefficient remains null across all three. <br>3. **Include a sensitivity analysis** that drops the 2016/17 transition wave altogether, retaining only pre‑2016 and post‑2021 observations, to assess whether the null persists when the sample is limited to children with full exposure. |
| **Power considerations** | 1. Because dental data are sparse (seven waves), supplement them with *regional* dental extraction counts from NHS Digital (if available) to increase the number of observations. Even if the outcome changes from a prevalence rate to a count, the Di‑D framework remains applicable with appropriate Poisson or negative‑binomial models. |

### C. Exploring Non‑Linear Deprivation Effects  

| Issue | Recommendation |
|-------|----------------|
| **Linear IMD interaction may be too restrictive** | 1. **Add quintile‑by‑post interaction terms** (as in the manifest) and present the results graphically (e.g., coefficient plot). This will allow the reader to see whether the highest‑deprivation quintile behaves differently from the rest. <br>2. **Test for a threshold effect** by including a spline or piecewise linear function (e.g., one slope for IMD < median, another for ≥ median). A Wald test can assess whether the slopes differ significantly. <br>3. **Report marginal effects**: translate the interaction coefficient(s) into “percentage‑point change in dental decay per SD increase in IMD” to aid interpretation. |
| **Interpretation of β₁ and β₂ – β₁** | 1. The paper mentions β₁ as the “reformulation‑only” effect and β₂ – β₁ as the “additional tax” effect but does not provide a clear economic interpretation or magnitude. Estimate the *implied* reduction in sugar intake per SD of IMD using external data on the relationship between sugar consumption and decay/obesity, and discuss whether the point estimates are substantively large or small. |

### D. Robustness and Sensitivity Checks  

| Recommendation |
|----------------|
| 1. **Cluster-robust inference** is appropriate, but with only ~350 clusters a wild‑cluster bootstrap (Cameron, Gelbach & Miller, 2008) can improve finite‑sample accuracy. Report whether the main p‑values change. |
| 2. **Alternative fixed‑effects specifications**: try including year‑by‑region (e.g., NHS region) interactions to absorb any region‑specific shocks that could be correlated with both deprivation and health outcomes. |
| 3. **Placebo timing**: shift the “announcement” dummy to a false year (e.g., 2014) and confirm that the interaction coefficient is zero. This falsification strengthens the credibility of the timing. |
| 4. **Check for spillovers**: if neighboring LAs with different deprivation levels experience differential market penetration of reformulated products, the SUTVA assumption could be violated. Using spatial lags of the treatment variable (e.g., average IMD of bordering LAs) can test for cross‑area contamination. |
| 5. **Alternative outcome definitions**: for obesity, consider the *severe* obesity cutoff (≥ 95th centile) or the *weight‐status* change between Reception and Year 6 (if data exist) to see whether the SDIL affected more extreme outcomes. |

### E. Presentation and Transparency  

| Recommendation |
|----------------|
| 1. **Provide a concise “identification diagram”** (e.g., a DAG) that spells out the causal pathway (announcement → reformulation → sugar intake → health outcomes) and highlights where the Di‑D identifies the effect. This helps readers see why deprivation is a valid intensity measure. |
| 2. **Make the data and code publicly available** (a GitHub repository with a README). The manuscript already mentions a repo, but ensure that the scripts for data extraction, cleaning, and regression are reproducible. |
| 3. **Standardise tables**: the current Table 2 contains “Within R² = 0.0000” which may look like a typo. Include the overall R², number of clusters, and a note on the cluster‑robust variance estimator used. |
| 4. **Clarify the interpretation of the “standardized effect size” table**: readers might misread the SDE as a significance test. A brief comment that the obesity SDE (≈ 0.14) corresponds to roughly a 0.4‑percentage‑point increase per SD of IMD would improve intuition. |
| 5. **Minor typographical fixes**: the word “reformulation‑only” is hyphenated inconsistently; ensure consistency throughout. Also, the reference list should include all cited works (e.g., “Band­y 2020” appears twice with different spellings). |

### F. Extending the Discussion  

| Recommendation |
|----------------|
| 1. **Policy relevance**: Elaborate on how the findings inform design of future sin taxes—e.g., consider hybrid designs that combine an industry‑wide reformulation target with a modest per‑unit tax to capture both supply‑side efficiency and demand‑side progressivity. <br>2. **Link to other sugar‑reduction policies**: Discuss whether complementary measures (e.g., front‑of‑pack labelling, school‑based nutrition programmes) could have synergistic effects with reformulation to reduce inequalities. <br>3. **International comparison**: Briefly note whether similar reformulation‑driven taxes elsewhere (e.g., Mexico, Chile) have generated equity gains, highlighting the contribution of this UK case study to the broader literature. |

---

**In summary**, the paper offers a valuable and novel contribution by assessing the equity impact of the SDIL via a continuous‑treatment Di‑D design. However, before the claim of “no equity effect” can be accepted, the authors must (i) resolve the pre‑trend violation for obesity, (ii) sharpen the exposure definition and lag structure for dental decay, and (iii) allow for non‑linear deprivation effects. Addressing these points—along with the additional robustness, presentation, and policy‑discussion suggestions above—will substantially improve the credibility and relevance of the work. I look forward to a revised version that incorporates these changes.
